Antimicrobial Host Defense Peptide | Immunomodulation & Wound Healing | For Research Use Only

LL-37 is a cationic antimicrobial peptide (AMP) derived from the human cathelicidin protein hCAP18. It plays a critical role in the innate immune response, offering both broad-spectrum antimicrobial activity and immune modulation. LL-37 is being extensively studied for its ability to fight bacterial, viral, and fungal infections, as well as its roles in tissue repair, wound healing, inflammation control, and anti-biofilm activity.

This peptide is of particular interest in skin regeneration, chronic wound therapy, autoimmune research, and anti-infective strategies.

🔍 Key Features

• Broad-Spectrum Antimicrobial Activity – Effective against bacteria, viruses, and fungi

• Disrupts Biofilms & Inhibits Pathogen Colonisation

• Promotes Wound Healing & Tissue Regeneration

• Modulates Immune Responses & Reduces Inflammation

• Studied in Skin Infections, Ulcers, and Immune Disorders

⚙️ Peptide Details

• Peptide Name: LL-37 (Cathelicidin antimicrobial peptide fragment)

• CAS Number: 143158-18-9

• Molecular Formula: C₁₁₂H₂₀₃N₃₅O₃₁

• Molecular Weight: ~4493.29 g/mol

• Purity: ≥ 98% (HPLC Verified)

• Form: Lyophilised white powder

• Unit Size: 5mg per vial

🧊 Storage & Handling

• Storage (lyophilised): Store at –20°C in a dry, dark place

• Reconstitution: Use sterile bacteriostatic water

• Post-Reconstitution: Store at 2–8°C and use within 7 days

• Avoid: Repeated freeze-thaw cycles and light exposure

⚠️ For Research Use Only

LL-37 – 5mg is supplied strictly for laboratory research and investigational purposes only. It is not for human consumption, therapeutic use, or medical application. Handle with proper lab safety protocols.